Readout AI's platform automatically analyzes data with the appropriate statistics and then describes the results in formats ranging from table descriptions to abstracts to posters. The goal is to alleviate the bottlenecks associated with clinical data analysis and reporting by turning trial data into accessible, human-readable insights, in seconds.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/15/23 | undisclosed | Pre-Seed |
Meridian Street Capital Mucker Capital Necessary Ventures Ryan Fukushima | undisclosed |
